Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Public Library of Science full text link Public Library of Science Free PMC article
Full text links

Actions

Share

.2016 Sep 9;11(9):e0162439.
doi: 10.1371/journal.pone.0162439. eCollection 2016.

Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression

Affiliations

Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression

Kayla A Boortz et al. PLoS One..

Abstract

Elevated fasting blood glucose (FBG) has been associated with increased risk for development of type 2 diabetes. Single nucleotide polymorphisms (SNPs) in G6PC2 are the most important common determinants of variations in FBG in humans. Studies using G6pc2 knockout mice suggest that G6pc2 regulates the glucose sensitivity of insulin secretion. G6PC2 and the related G6PC1 and G6PC3 genes encode glucose-6-phosphatase catalytic subunits. This study describes a functional analysis of 22 non-synonymous G6PC2 SNPs, that alter amino acids that are conserved in human G6PC1, mouse G6pc1 and mouse G6pc2, with the goal of identifying variants that potentially affect G6PC2 activity/expression. Published data suggest strong conservation of catalytically important amino acids between all four proteins and the related G6PC3 isoform. Because human G6PC2 has very low glucose-6-phosphatase activity we used an indirect approach, examining the effect of these SNPs on mouse G6pc1 activity. Using a novel in situ functional assay for glucose-6-phosphatase activity we demonstrate that the amino acid changes associated with the human G6PC2 rs144254880 (Arg79Gln), rs149663725 (Gly114Arg) and rs2232326 (Ser324Pro) SNPs reduce mouse G6pc1 enzyme activity without affecting protein expression. The Arg79Gln variant alters an amino acid mutation of which, in G6PC1, has previously been shown to cause glycogen storage disease type 1a. We also demonstrate that the rs368382511 (Gly8Glu), rs138726309 (His177Tyr), rs2232323 (Tyr207Ser) rs374055555 (Arg293Trp), rs2232326 (Ser324Pro), rs137857125 (Pro313Leu) and rs2232327 (Pro340Leu) SNPs confer decreased G6PC2 protein expression. In summary, these studies identify multiple G6PC2 variants that have the potential to be associated with altered FBG in humans.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Conservation of Amino Acids Between Human 12, Mouse G6pc2, Human G6PC1 and Mouse G6pc1.
Sequence alignment showing the conservation of AAs between human (h) G6PC2, mouse (m) G6pc2, human G6PC1 and mouse G6pc1. Residues highlighted in green represent AAs mutation of which in G6PC1 causes GSD type 1a [40]. Residues highlighted in pink represent AAs that are changed by humanG6PC2 SNPs that were identified using the UCSC Genome Browser (https://genome.ucsc.edu/) and HumSAVR (http://omictools.com/humsavar-tool) databases. Residues highlighted in yellow represent conserved AAs in human G6PC2, mouse G6pc2, human G6PC1 and mouse G6pc1 that are changed by a humanG6PC2 SNP and where mutation in G6PC1 can cause GSD type 1a. Identities are indicated by filled circles and similarities by vertical bars.
Fig 2
Fig 2. Glucose-Regulated Fusion Gene Expression in 832/13 Cells.
832/13 cells were transiently co-transfected, as described in Materials and Methods, with an expression vector encodingRenilla luciferase (0.5 μg) andPklr-luciferase orG6pc1-luciferase fusion genes (2 μg) containing the promoter regions from -206 to +1 and -7253 to +66, respectively, (Panels A andC) or the indicated promoter regions (Panel B). Following transfection, cells were incubated for 18–20 hr in serum-free medium in the presence of the indicated concentrations of glucose (Glc) or mannitol (Mann). Cells were then harvested and luciferase activity assayed as described in Materials and Methods. Results are presented as the ratio of firefly:Renilla luciferase activity (Panels A andB) or a percentage of the induction achieved with 30 mM glucose (Panel C). Results represent the mean ± S.E.M. of 3 experiments using independent preparations of all fusion gene constructs in which each experimental condition was assayed in triplicate.
Fig 3
Fig 3. Overexpression of G6pc1 Suppresses Glucose-Stimulated Fusion Gene Expression in 832/13 Cells.
Panel A: Schematic illustrating how the extent of glucose cycling catalyzed by glucokinase and G6pc1 determines intracellular G6P levels and hence activation of fusion gene expression through ChREBP and CREB.Panel B: Western blot showing that wild type (WT) and catalytically dead (D) G6pc1 are expressed at similar levels following expression in 832/13 cells. A representative blot is shown.Panel C: 832/13 cells were transiently co-transfected, as described in Materials and Methods, with the -206/+1Pklr-luciferase or -7248/+62G6pc1-luciferase fusion genes (2 μg), an expression vectors encodingRenilla luciferase (0.5 μg) and the indicated amounts of expression vectors encoding either wild type (WT) or catalytically dead (D) G6pc1. The total DNA added was kept constant using the empty pcDNA3 vector. Following transfection, cells were incubated for 18–20 hr in serum-free medium in the presence of 30 mM glucose. Cells were then harvested and luciferase activity assayed as described in Materials and Methods. Results were calculated as the ratio of firefly:Renilla luciferase activity and are presented as a percentage relative to that in 30 mM glucose-treated cells transfected with the empty pcDNA3 vector (2 μg). Results represent the mean ± S.E.M. of 3 experiments using independent preparations of both fusion gene constructs in which each experimental condition was assayed in triplicate.Panel D: 832/13 cells were transiently co-transfected, as described in Materials and Methods, with the -206/+1Pklr-luciferase or -7248/+62G6pc1-luciferase fusion genes (2 μg), an expression vectors encodingRenilla luciferase (0.5 μg) and 2 μg of expression vectors encoding either wild type (WT) or catalytically dead (D) G6pc1. Following transfection, cells were incubated for 18–20 hr in serum-free medium in the presence of the indicated glucose concentrations. Cells were then harvested and luciferase activity assayed as described in Materials and Methods. Results were calculated as the ratio of firefly:Renilla luciferase activity and are presented as a percentage relative to that in 30 mM glucose-treated cells in the presence of catalytically dead G6pc1. Results represent the mean ± S.E.M. of 3 experiments using independent preparations of both fusion gene constructs in which each experimental condition was assayed in triplicate.
Fig 4
Fig 4. Analysis of the Effect of Amino Acid Changes on Mouse G6pc1 Protein Expression.
832/13 cells were transiently transfected, as described in Materials and Methods, with expression vectors encoding either wild type (WT) mouse (m) G6pc1 or G6pc1 variants in which the indicated amino acid (AA) had been changed as shown in Table 1. Following transfection, cells were incubated for 18–20 hr in serum-containing medium. Cells were then harvested and protein expression assayed as described in Materials and Methods. In some instances these AA changes did not affect G6pc1 protein expression (Panels A-C). In other cases they resulted in reduced expression (Panel D); these data were quantitated by scanning with the results inPanel E showing the mean ± S.E.M. of 4 experiments. For simplicity and comparison with Fig 8, these AAs are numbered based on the position of the equivalent conserved AA in human G6PC2 (Fig 1).
Fig 5
Fig 5. Analysis of HumanG6PC2 and MouseG6pc2 mRNA and Protein Expression.
COS 7 cells were transiently transfected, as described in Materials and Methods, with expression vectors encoding either wild type (WT) mouse (m) G6pc2, human (h) G6PC2 or the empty pcDNA3 vector. Following transfection, cells were incubated for 18–20 hr in serum-containing medium. Cells were then harvested and either RNA (Panel A) or protein (Panel B) expression were assayed as described in Materials and Methods. A representative agarose gel (Panel A) or Western blot (Panel B) are shown. The faint band of the same size in the empty vector transfected cells represents background plasmid contamination of our PCR reagents/tubes.
Fig 6
Fig 6. Analysis of Human G6PC2:Mouse G6pc2 Chimeric Protein Expression.
832/13 cells were transiently transfected, as described in Materials and Methods, with expression vectors encoding either wild type mouse (m) G6pc2, human (h) G6PC2 or the indicated chimeric proteins (Panel A). Following transfection, cells were incubated for 18–20 hr in serum-containing medium. Cells were then harvested and protein expression assayed as described in Materials and Methods (Panel B). A representative blot is shown.
Fig 7
Fig 7. Analysis of the Effect of HumanG6PC2 Codon Variation on Protein Expression.
832/13 cells were transiently transfected, as described in Materials and Methods, with expression vectors encoding either wild type (WT) mouse (m) G6pc2, human (h) G6PC2 or G6PC2 variants in which the codon used to encode the indicated AAs had been optimized as shown in S2 Table and S3 Table. Following transfection, cells were incubated for 18–20 hr in serum-containing medium. Cells were then harvested and protein expression assayed as described in Materials and Methods. In some instances codon optimization resulted in a switch to the same codon used to encode the equivalent AA in mouse G6pc2 (Panel A; S2 Table). In other cases this resulted in a switch to a codon that was distinct from the codon used to encode the equivalent AA in mouse G6pc2 (Panel B; S3 Table). Representative blots are shown.
Fig 8
Fig 8. Analysis of the Effect of HumanG6PC2 SNPs on Human G6PC2 Protein Expression.
COS 7 cells were transiently transfected, as described in Materials and Methods, with expression vectors encoding either wild type (WT) human (h) G6PC2 or G6PC2 variants in which the indicated amino acid (AA) had been changed as shown in Table 1. Following transfection, cells were incubated for 18–20 hr in serum-containing medium. Cells were then harvested and protein expression assayed as described in Materials and Methods. The variants shown either reduced (Panels A-D) or had little effect (Panel E) on human G6PC2 protein expression. Data were quantitated by scanning with the results inPanels B andD showing the mean ± S.E.M. of 4 experiments. Representative blots are shown.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abdul-Ghani MA, DeFronzo RA (2009) Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32 Suppl 2: S194–198. 10.2337/dc09-S309 - DOI - PMC - PubMed
    1. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233–240. - PubMed
    1. Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, et al. (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27: 2836–2842. - PubMed
    1. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116. 10.1038/ng.520 - DOI - PMC - PubMed
    1. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44: 991–1005. 10.1038/ng.2385 - DOI - PMC - PubMed

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Public Library of Science full text link Public Library of Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp